ARCHIVES

FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+.

This article is from The Cancer Letter archive.

Vol. 26 No. 22 | June 2, 2000

Download PDF Visit The Full Archive

Related Articles

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

June 16, 1999

Source Identified for Hepatitis A Contamination of LAK-IL-2 Trials; Six MIs Seen; Rosenberg Updates Intramural Results

October 24, 1986

NMP22 Assay More Effective Than Conventional Lab Test

January 27, 2006

Masons Give $65 Million to Univ. of Minnesota Cancer Center.

April 25, 2008

In Brief: CREG To Be Used In Viral Oncology, Nutrition, Cell Kinetics, Immunology, Rauscher Tells NCAB

April 4, 1975

NCI To Offer Expanded Access To Oxaliplatin

May 31, 2002